TGFβ biology in cancer progression and immunotherapy
Nature Reviews Clinical Oncology, Published online: 24 July 2020; doi:10.1038/s41571-020-0403-1TGFβ released by cancer cells and other cells in the tumour microenvironment enables cancer cell invasion and dissemination, stem cell properties and therapeutic resistance as well as generating an immunosuppressive environment. The authors of this Review introduce the mechanisms underlying TGFβ signalling in tumours and their microenvironment and discuss approaches to inhibit these signalling mechanisms, in particular in the context of cancer immunotherapy.
Source: Nature Reviews Clinical Oncology - Category: Cancer & Oncology Authors: Rik Derynck Shannon J. Turley Rosemary J. Akhurst Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Environmental Health | Immunotherapy | Rosemary | Stem Cell Therapy | Stem Cells